Coronavirus vaccine

New Delhi: The Subject Expert Committee (SEC) on COVID-19 in India CDSCO has recommended phase 3 clinical trial of Sputnik Light as a booster dose, PTI reported on Saturday. Dr...

Pune: Serum Institute of India (SII) has sought emergency use authorisation (EUA) for its COVID-19 vaccine Covovax for the 12-17 age group. Prakash Kumar Singh, Director, Government and Regulatory Affairs...

New Delhi: Drugs Controller General of India (DCGI) on Monday approved Biological E’s Covid-19 vaccine Corbevax for emergency use among children aged 12-18 years. The Hyderabad-based pharmaceutical company’s vaccine had...

Berhampur: A team of Indian scientists from Berhampur’s Indian Institute of Science Education and Research (IISER) in Odisha and Kazi Nazrul University (KNU) in Asansol claim to have developed a...

Washington: A fourth jab of the COVID-19 vaccine may be needed as a further booster dose in the fight against the Omicron variant. That is what USA’s Chief Medical advisor...

New Delhi: The Union government told Supreme Court on Monday that Aadhaar card is not mandatory to register for vaccination on CoWIN portal. The Ministry of Health and Family Welfare...

New Delhi: Sputnik Light, Russia’s single-dose COVID-19 vaccine, was on Sunday granted emergency use approval in India by Drugs Controller General of India (DCGI). Developed by Russia’s Gamaleya Center, Sputnik...

New Delhi: The Union government has placed an order with Biological E to purchase 5 crore doses of Corbevax COVID-19 vaccine. The cost of each dose is Rs 145, excluding...

Hyderabad: India started vaccinating children in the age group of 15-18 years with Covaxin from January 3. As experts are calling for opening up the COVID-19 jab for 12-15 and...

New Delhi: Bharat Biotech on Friday received approval from the Drugs Controller General of India (DCGI) to conduct its intranasal COVID-19 booster dose trials in India. The trials are likely...